Jan Lötvall (also spelled Lotvall) is a Swedish clinical allergist and scientist working on translational research primarily in the field of asthma.
He is the former director of the Krefting Research Centre at the University of Gothenburg[1] and is the Chief Scientific Officer of ExoCoBio.
[2][3] Lötvall's laboratory proposed extracellular vesicles such as exosomes and microvesicles as shuttles of RNA molecules between cells[4] along with several other groups in 2006,[5] 2007,[6] and 2008.
Lötvall studied medicine at the Karolinska Institutet in Stockholm (1981–1985) and graduated from the Medical School of the University of Gothenburg in 1987.
After studying as a visiting fellow at the National Heart and Lung Institute, London from 1988 to 1990), Lötvall defended his thesis in February, 1991.